Breakthrough in COVID-19 Treatment: Allicin-Nanocomplexes Show Promise

Strategic Insights -

Researchers from Islamic Azad University in Iran have made a significant discovery in the fight against COVID-19, finding that allicin-nanocomplexes exhibit strong binding affinity and favorable electronic properties, making them a promising candidate for treating the disease. The study, published in Scientific Reports, used advanced computational techniques to investigate the anti-inflammatory, anticancer, antiviral, and antibacterial effects of allicin and its complexes. The findings suggest that the Allicin/Al N complex can enhance the stability, bioavailability, and therapeutic potential of allicin, offering new hope in the treatment of COVID-19.

Key Takeaways:

  • The Allicin/Al N complex showed the highest adsorption energy (Ead = -44.43 kcal/mol in the gas phase) and thermodynamic stability (DH = -44.36 kcal/mol, DG = -29.19 kcal/mol) among the investigated complexes.
  • Molecular docking demonstrated that the Allicin/Al N complex had the strongest binding affinity with biological targets, including HER2, TNF-α, COVID-19 main protease, and Staphylococcus aureus.
  • Ultraviolet-visible (UV-Vis) and infrared (IR) spectroscopy revealed significant electronic and vibrational modifications in the complexes, particularly Allicin/Al N.
  • The study highlights the importance of natural products in drug discovery and the role of computational methods in understanding complex biological interactions.
  • The research involved a team of scientists from Islamic Azad University, including E. S. Mozafari, Mohammad T. Baei, and E. Tazikeh Lemeski.

Statistics:

  • The Allicin/Al N complex exhibited a reduced energy gap (3.44 eV) compared to free allicin (5.42 eV).
  • The study found that the Allicin/Al N complex showed a higher reactivity than free allicin, with a reactivity index of 5.42 eV.
  • The computational study used Density Functional Theory (DFT), Quantum Theory of Atoms in Molecules (QTAIM), and molecular docking techniques to investigate the therapeutic properties of allicin and its nanocomplexes.

Sources:

  • Computational study of the therapeutic properties of allicin and its nanocomplexes using DFT and molecular docking techniques. Scientific Reports, 2025;15(1):23034. Scientific Reports can be contacted at: Nature Portfolio, Heidelberger Platz 3, Berlin, 14197, Germany.